Stage IVB Colorectal Cancer Recruiting Phase 3 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0068497 (Stage IVB Colorectal Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02997228Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal CancerTreatment